Compare Alcon AG (ALC) vs Salesforce Inc (CRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alcon AG vs Salesforce Inc — how do they compare? Alcon AG trades at $71.74 (market cap $34.99B), while Salesforce Inc trades at $258.59 (market cap $211.96B). The key difference: Salesforce Inc is far larger — about 6.1× Alcon AG's market cap, and Salesforce Inc pays the higher dividend (0.68%). Which is the better fit depends on your goals.
| ALC | CRM | |
|---|---|---|
Market Cap | $34.99B | $211.96B |
Sector | Health | Technology |
52-Week High | $87.18 | $266.23 |
52-Week Low | $62.02 | $150.12 |
Enterprise Value | $38.83B | $242.30B |
Dividend Yield | 0.5% | 0.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $71.85, down 0.22% with bearish technical signals despite recent earnings beats. The company shows solid revenue growth to $10.4B in 2025 but faces margin compression with net income declining to $980M. Recent news highlights strong Q2 2026 performance and raised profit guidance, while Bill Ackman's new position adds institutional confidence. Valuation remains elevated with a P/E of 55.01, though analyst consensus targets $85.85 upside.
ALC presents a mixed outlook with strong operational execution offset by valuation concerns. The stock offers potential upside to analyst targets but faces headwinds from margin pressure and bearish technical momentum. Key catalysts include continued product launches and tariff relief benefits, while risks include competitive pressures and execution challenges in maintaining profitability growth.
Salesforce (CRM) trades at $257.05, up 0.41% today, with a bullish technical signal from moving averages but overbought RSI readings. The company demonstrates strong fundamentals with consistent earnings beats, including Q2 2026 EPS of $5.90 versus $3.27 expected, and robust profitability margins. Recent news highlights AI-driven growth potential amid market volatility.
Outlook remains positive with analyst consensus favoring Buy (75.78%) and a $263.56 price target. Key opportunities include AI monetization and double-digit revenue growth, while risks involve competitive pressures and macroeconomic sensitivity. The stock presents a growth-oriented investment with solid financial health.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →
